Evidence map›Paper›PMID 39249633›Full record

SynthesisEndocrine2025

Diagnostic performance of 2-[

Domenico Albano, Arnoldo Piccardo, Alessio Rizzo, Marco Cuzzocrea, Gianluca Bottoni, Pietro Bellini, Francesco Bertagna, Giorgio Treglia

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The Role ofMedical sciences (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Clinico-pathological factors and [BMC medical imaging · 2024
    Article
  4. Review
  5. Role of [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Domenico AlbanoUniversità degli Studi di Brescia, Brescia, Italy. doalba87@libero.it.ORCID 0000-0003-0810-6494
Arnoldo PiccardoDepartment of Nuclear Medicine, E.O. "Ospedali Galliera", Genoa, Italy.
Alessio RizzoNuclear Medicine Division, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Marco CuzzocreaDivision of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Gianluca BottoniDepartment of Nuclear Medicine, E.O. "Ospedali Galliera", Genoa, Italy.
Pietro BelliniUniversità degli Studi di Brescia, Brescia, Italy.
Francesco BertagnaUniversità degli Studi di Brescia, Brescia, Italy.
Giorgio TregliaDivision of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis updated systematic review and bivariate meta-analysis aimed to investigate the diagnostic performance of 2-[

methodsThe current systematic review was carried out following a preset protocol, and the "Preferred Reporting Items for a Systematic Review and Meta-Analysis" served as a guideline for its development and reporting. A comprehensive research of the PubMed/MEDLINE, Embase and Cochrane library databases was conducted until June 2024.

resultsBetween 2002 and 2023, 13 studies (608 patients) published on this topic were selected. The pooled sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 2-[

conclusions2-[

Indexed as

AutoantibodiesNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyThyroid NeoplasmsFluorodeoxyglucose F18HumansRadiopharmaceuticalsanti-thyroglobulinAutoantibodiesFluorodeoxyglucose F18Radiopharmaceuticals18F-FDGAnti-thyroglobulin antibodyDTCPET/CTThyroid cancer

Identifiers

PMID39249633
PMCPMC11811433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.